Commercial

Moberg Pharma joins hands with Allderma to market nail fungus product in Scandinavia

Moberg pharma joins hands with Allderma to enter the market with a new nail fungus product named MOB-015. Moberg...

U.S. to buy additional $1B of Merck’s Covid-19 drug

In the latest Merck’s COVID-19 news, it was reported that President Biden’s government has plans to place an order for another batch...

Merck acquires Acceleron Pharma for $11.5B to expand cardiovascular pipeline

To aid the growth of its expanding cardiovascular treatments pipeline, Merck is striking an acquisition deal worth $11.5B with the Acceleron Pharma....

Renewed Drug-Pricing Plan by White House Looms over Biotech and Pharma Industry

The White House is all set to announce a price reduction plan for prescription drugs and the very news is looming over...

Gilead, Merck and other big pharmas engaged in illicit “pay-for-delay” deals to retain their lucrative HIV and cholesterol meds supremacy

Gilead and Merck, along with some other renowned pharmaceutical companies, are involved in “pay-for-delay” deals to settle with the rising generic competitors...

Amarin goes from conventional to digital marketing for its icosapent ethyl drug VASCEPA

Amarin, an Irish-American biopharmaceutical company, revealed last week that the company is going to downsize its sales representatives by more than 50%,...

Takeda looks to expand vaccine business with traction in Covid-19 and dengue

The Japanese pharmaceutical company Takeda is collaborating with Moderna and Novavax to have their COVID-19 vaccines accessible in Japan. Takeda’s CEO sees...

Purdue Pharma’s exeuctives to get $7M bonus authorized by federal judge

A U.S. federal judge upon approving bonuses of $7.1 million for five executive members of Purdue Pharma, received denunciation from a mother...

Latest news

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Many people find booking plane tickets, arranging road transportation and overnight lodging overwhelming. Add into that mix...
- Advertisement -

China forces insulin price cuts resulting in pullback for global pharma players

Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by...

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks to buy Vifor Pharma in a deal that is valued...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Pharma Industry to Spend $4.5 Billion on Digital Transformation by 2030

The industry's unique characteristics are driving investments in digital transformation by pharmaceutical manufacturers.

Boston Pharmaceuticals and GSK enter pact for advancement of early stage cancer, CNS programs

Boston Pharmaceuticals announced today a pioneering three-year out-license and option agreement

Roche partners with Diabeloop to integrate automated insulin delivery

As part of the deal, users will be able to integrate Roche's Accu-Chek Insights insulin pump with the Diabeloop monitoring system.
Nominations for Top Industry Leaders Awards are now open!